Ajax loader
By using our website, you agree to our use of cookies as described in Cookie Policy.

Can't find what you're looking for?

 

Be sure to Sign in to see all available content.

 

If you don't have an account, Register here.

Search results for: Food-manufacture

HEALTH-CORONAVIRUS/USA-CONGRESS
RTS3A6UG
June 02, 2020
Deputy Director for Regulatory Programs, Center for Drug Evaluation and Research Food and Drug Administration,...
Washington, UNITED STATES
Senate Finance Committee
Deputy Director for Regulatory Programs, Center for Drug Evaluation and Research Food and Drug Administration, Douglas Throckmorton speaks by video conference during a Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, U.S., June 2, 2020. Andrew Caballero-Reynolds/Pool via REUTERS
HEALTH-CORONAVIRUS/USA-CONGRESS
RTS3A6U9
June 02, 2020
Associate Commissioner for Regulatory Affairs, Office of Regulatory Affairs Food and Drug Administration,...
Washington, UNITED STATES
Senate Finance Committee
Associate Commissioner for Regulatory Affairs, Office of Regulatory Affairs Food and Drug Administration, Judith A. McMeekin speaks during a Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, U.S., June 2, 2020. Andrew Caballero-Reynolds/Pool via REUTERS
HEALTH-CORONAVIRUS/USA-CONGRESS
RTS3A6U5
June 02, 2020
Associate Commissioner for Regulatory Affairs, Office of Regulatory Affairs Food and Drug Administration,...
Washington, UNITED STATES
Senate Finance Committee
Associate Commissioner for Regulatory Affairs, Office of Regulatory Affairs Food and Drug Administration, Judith A. McMeekin speaks during a Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, U.S., June 2, 2020. Andrew Caballero-Reynolds/Pool via REUTERS
HEALTH-CORONAVIRUS/USA-CONGRESS
RTS3A6U0
June 02, 2020
Associate Commissioner for Regulatory Affairs, Office of Regulatory Affairs Food and Drug Administration,...
Washington, UNITED STATES
Senate Finance Committee
Associate Commissioner for Regulatory Affairs, Office of Regulatory Affairs Food and Drug Administration, Judith A. McMeekin speaks during a Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, U.S., June 2, 2020. Andrew Caballero-Reynolds/Pool via REUTERS
HEALTH-CORONAVIRUS/USA-CONGRESS
RTS3A6TX
June 02, 2020
Associate Commissioner for Global Policy and Strategy at the Food and Drug Administration, Mark Abdoo...
Washington, UNITED STATES
Senate Finance Committee
Associate Commissioner for Global Policy and Strategy at the Food and Drug Administration, Mark Abdoo looks on during a Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, U.S., June 2, 2020. Andrew Caballero-Reynolds/Pool via REUTERS
HEALTH-CORONAVIRUS/USA-CONGRESS
RTS3A6TW
June 02, 2020
Associate Commissioner for Global Policy and Strategy at the Food and Drug Administration, Mark Abdoo...
Washington, UNITED STATES
Senate Finance Committee
Associate Commissioner for Global Policy and Strategy at the Food and Drug Administration, Mark Abdoo speaks during a Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, U.S., June 2, 2020. Andrew Caballero-Reynolds/Pool via REUTERS
HEALTH-CORONAVIRUS/USA-CONGRESS
RTS3A6QO
June 02, 2020
Douglas Throckmorton M.D., Deputy Director for Regulatory Programs at the Food and Drug Administration...
Washington, United States of America
Senate Finance Committee
Douglas Throckmorton M.D., Deputy Director for Regulatory Programs at the Food and Drug Administration (FDA) speaks via teleconference during the Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, U.S., June 2, 2020. Stefani Reynolds/Pool via REUTERS
HEALTH-CORONAVIRUS/USA-CONGRESS
RTS3A6QN
June 02, 2020
Douglas Throckmorton M.D., Deputy Director for Regulatory Programs at the Food and Drug Administration...
Washington, United States of America
Senate Finance Committee
Douglas Throckmorton M.D., Deputy Director for Regulatory Programs at the Food and Drug Administration (FDA) speaks via teleconference during the Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, U.S., June 2, 2020. Stefani Reynolds/Pool via REUTERS
HEALTH-CORONAVIRUS/USA-CONGRESS
RTS3A6QL
June 02, 2020
Mark Abdoo, Associate Commissioner for Global Policy and Strategy at the Food and Drug Administration...
Washington, United States of America
Senate Finance Committee
Mark Abdoo, Associate Commissioner for Global Policy and Strategy at the Food and Drug Administration (FDA), listens during the Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, U.S., June 2, 2020. Stefani Reynolds/Pool via REUTERS
HEALTH-CORONAVIRUS/USA-CONGRESS
RTS3A6QK
June 02, 2020
United States Senator Tom Carper (Democrat of Delaware), center, speaks to Judith McMeekin, Associate...
Washington, United States of America
Senate Finance Committee
United States Senator Tom Carper (Democrat of Delaware), center, speaks to Judith McMeekin, Associate Commissioner for Regulatory Affairs at the Food and Drug Administration (FDA), right, and Mark Abdoo, Associate Commissioner for Global Policy and Strategy at the Food and Drug Administration FDA), before leaving the Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, U.S., June 2, 2020. Stefani Reynolds/Pool via REUTERS
HEALTH-CORONAVIRUS/USA-CONGRESS
RTS3A6QI
June 02, 2020
Judith McMeekin, Associate Commissioner for Regulatory Affairs at the Food and Drug Administration (FDA),...
Washington, United States of America
Senate Finance Committee
Judith McMeekin, Associate Commissioner for Regulatory Affairs at the Food and Drug Administration (FDA), right, and Mark Abdoo, Associate Commissioner for Global Policy and Strategy at the Food and Drug Administration (FDA), listen during the Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, U.S., June 2, 2020. Stefani Reynolds/Pool via REUTERS
HEALTH-CORONAVIRUS/USA-CONGRESS
RTS3A6QB
June 02, 2020
Judith McMeekin, Associate Commissioner for Regulatory Affairs at the Food and Drug Administration (FDA),...
Washington, United States of America
Senate Finance Committee
Judith McMeekin, Associate Commissioner for Regulatory Affairs at the Food and Drug Administration (FDA), right, and Mark Abdoo, Associate Commissioner for Global Policy and Strategy at the Food and Drug Administration (FDA), listen during the Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, U.S., June 2, 2020. Stefani Reynolds/Pool via REUTERS
HEALTH-CORONAVIRUS/USA-CONGRESS
RTS3A6Q8
June 02, 2020
Judith McMeekin, Associate Commissioner for Regulatory Affairs at the Food and Drug Administration (FDA),...
Washington, United States of America
Senate Finance Committee
Judith McMeekin, Associate Commissioner for Regulatory Affairs at the Food and Drug Administration (FDA), right, and Mark Abdoo, Associate Commissioner for Global Policy and Strategy at the Food and Drug Administration (FDA), listen during the Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, U.S., June 2, 2020. Stefani Reynolds/Pool via REUTERS
HEALTH-CORONAVIRUS/USA-CONGRESS
RTS3A6Q7
June 02, 2020
Judith McMeekin, Associate Commissioner for Regulatory Affairs at the Food and Drug Administration (FDA),...
Washington, United States of America
Senate Finance Committee
Judith McMeekin, Associate Commissioner for Regulatory Affairs at the Food and Drug Administration (FDA), right, and Mark Abdoo, Associate Commissioner for Global Policy and Strategy at the Food and Drug Administration (FDA), listen during the Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, U.S., June 2, 2020. Stefani Reynolds/Pool via REUTERS
HEALTH-CORONAVIRUS/USA-CONGRESS
RTS3A6Q2
June 02, 2020
Judith McMeekin, Associate Commissioner for Regulatory Affairs at the Food and Drug Administration (FDA)...
Washington, United States of America
Senate Finance Committee
Judith McMeekin, Associate Commissioner for Regulatory Affairs at the Food and Drug Administration (FDA) listens during the Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, U.S., June 2, 2020. Stefani Reynolds/Pool via REUTERS
HEALTH-CORONAVIRUS/USA-CONGRESS
RTS3A6PR
June 02, 2020
Associate Commissioner for Regulatory Affairs, Office of Regulatory Affairs Food and Drug Administration,...
Washington, UNITED STATES
Senate Finance Committee
Associate Commissioner for Regulatory Affairs, Office of Regulatory Affairs Food and Drug Administration, Judith A. McMeekin and Associate Commissioner for Global Policy and Strategy, Food and Drug Administration, Mark Abdoo look on during a Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, U.S., June 2, 2020. Andrew Caballero-Reynolds/Pool via REUTERS
HEALTH-CORONAVIRUS/USA-CONGRESS
RTS3A6PQ
June 02, 2020
Associate Commissioner for Regulatory Affairs, Office of Regulatory Affairs Food and Drug Administration,...
Washington, UNITED STATES
Senate Finance Committee
Associate Commissioner for Regulatory Affairs, Office of Regulatory Affairs Food and Drug Administration, Judith A. McMeekin and Associate Commissioner for Global Policy and Strategy, Food and Drug Administration, Mark Abdoo look on during a Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, U.S., June 2, 2020. Andrew Caballero-Reynolds/Pool via REUTERS
HEALTH-CORONAVIRUS/USA-CONGRESS
RTS3A6PO
June 02, 2020
Associate Commissioner for Regulatory Affairs, Office of Regulatory Affairs Food and Drug Administration,...
Washington, UNITED STATES
Senate Finance Committee
Associate Commissioner for Regulatory Affairs, Office of Regulatory Affairs Food and Drug Administration, Judith A. McMeekin looks on as Associate Commissioner for Global Policy and Strategy, Food and Drug Administration, Mark Abdoo speaks during a Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, U.S., June 2, 2020. Andrew Caballero-Reynolds/Pool via REUTERS
HEALTH-CORONAVIRUS/USA-CONGRESS
RTS3A6P6
June 02, 2020
US Deputy Director for Regulatory Programs of the Center for Drug Evaluation and Research at the Food...
Washington, UNITED STATES
Senate Finance Committee
US Deputy Director for Regulatory Programs of the Center for Drug Evaluation and Research at the Food and Drug Administration, Douglas Throckmorton speaks by video conference during a Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, U.S., June 2, 2020. Andrew Caballero-Reynolds/Pool via REUTERS
HEALTH-CORONAVIRUS/USA-CONGRESS
RTS3A6LC
June 02, 2020
Mary Denigan-Macauley, Ph.D., Director of Health Care at the United States Government Accountability...
Washington, United States of America
Senate Finance Committee
Mary Denigan-Macauley, Ph.D., Director of Health Care at the United States Government Accountability Office, left, speaks via teleconference as Judith McMeekin, Associate Commissioner for Regulatory Affairs at the Food and Drug Administration (FDA), right, and Mark Abdoo, Associate Commissioner for Global Policy and Strategy at the Food and Drug Administration (FDA), listen during the Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, U.S., June 2, 2020. Stefani Reynolds/Pool via REUTERS
HEALTH-CORONAVIRUS/USA-CONGRESS
RTS3A6LB
June 02, 2020
Douglas Throckmorton M.D., Deputy Director for Regulatory Programs at the Food and Drug Administration...
Washington, United States of America
Senate Finance Committee
Douglas Throckmorton M.D., Deputy Director for Regulatory Programs at the Food and Drug Administration (FDA) speaks via teleconference as United States Senator Todd Young (Republican of Indiana) looks over notes during the Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, U.S., June 2, 2020. Stefani Reynolds/Pool via REUTERS
HEALTH-CORONAVIRUS/USA-CONGRESS
RTS3A6L9
June 02, 2020
Douglas Throckmorton M.D., Deputy Director for Regulatory Programs at the Food and Drug Administration...
Washington, United States of America
Senate Finance Committee
Douglas Throckmorton M.D., Deputy Director for Regulatory Programs at the Food and Drug Administration (FDA) speaks via teleconference during the Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, U.S., June 2, 2020. Stefani Reynolds/Pool via REUTERS
HEALTH-CORONAVIRUS/USA-CONGRESS
RTS3A6L8
June 02, 2020
Douglas Throckmorton M.D., Deputy Director for Regulatory Programs at the Food and Drug Administration...
Washington, United States of America
Senate Finance Committee
Douglas Throckmorton M.D., Deputy Director for Regulatory Programs at the Food and Drug Administration (FDA) speaks via teleconference during the Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, U.S., June 2, 2020. Stefani Reynolds/Pool via REUTERS
HEALTH-CORONAVIRUS/USA-CONGRESS
RTS3A6L0
June 02, 2020
Judith McMeekin, Associate Commissioner for Regulatory Affairs at the Food and Drug Administration (FDA)...
Washington, United States of America
Senate Finance Committee
Judith McMeekin, Associate Commissioner for Regulatory Affairs at the Food and Drug Administration (FDA) speaks during the Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, U.S., June 2, 2020. Stefani Reynolds/Pool via REUTERS
HEALTH-CORONAVIRUS/USA-CONGRESS
RTS3A6KZ
June 02, 2020
Judith McMeekin, Associate Commissioner for Regulatory Affairs at the Food and Drug Administration (FDA)...
Washington, United States of America
Senate Finance Committee
Judith McMeekin, Associate Commissioner for Regulatory Affairs at the Food and Drug Administration (FDA) speaks during the Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, U.S., June 2, 2020. Stefani Reynolds/Pool via REUTERS
HEALTH-CORONAVIRUS/USA-CONGRESS
RTS3A6KY
June 02, 2020
Judith McMeekin, Associate Commissioner for Regulatory Affairs at the Food and Drug Administration (FDA),...
Washington, United States of America
Senate Finance Committee
Judith McMeekin, Associate Commissioner for Regulatory Affairs at the Food and Drug Administration (FDA), right, and Mark Abdoo, Associate Commissioner for Global Policy and Strategy at the Food and Drug Administration (FDA), listen during the Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, U.S., June 2, 2020. Stefani Reynolds/Pool via REUTERS
HEALTH-CORONAVIRUS/USA-CONGRESS
RTS3A6KX
June 02, 2020
Judith McMeekin, Associate Commissioner for Regulatory Affairs at the Food and Drug Administration (FDA),...
Washington, United States of America
Senate Finance Committee
Judith McMeekin, Associate Commissioner for Regulatory Affairs at the Food and Drug Administration (FDA), right, and Mark Abdoo, Associate Commissioner for Global Policy and Strategy at the Food and Drug Administration (FDA), listen during the Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, U.S., June 2, 2020. Stefani Reynolds/Pool via REUTERS
HEALTH-CORONAVIRUS/USA-CONGRESS
RTS3A6KT
June 02, 2020
Judith McMeekin, Associate Commissioner for Regulatory Affairs at the Food and Drug Administration (FDA),...
Washington, United States of America
Senate Finance Committee
Judith McMeekin, Associate Commissioner for Regulatory Affairs at the Food and Drug Administration (FDA), right, and Mark Abdoo, Associate Commissioner for Global Policy and Strategy at the Food and Drug Administration (FDA), listen during the Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, U.S., June 2, 2020. Stefani Reynolds/Pool via REUTERS
HEALTH-CORONAVIRUS/USA-CONGRESS
RTS3A6KR
June 02, 2020
Judith McMeekin, Associate Commissioner for Regulatory Affairs at the Food and Drug Administration (FDA)...
Washington, United States of America
Senate Finance Committee
Judith McMeekin, Associate Commissioner for Regulatory Affairs at the Food and Drug Administration (FDA) speaks during the Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, U.S., June 2, 2020. Stefani Reynolds/Pool via REUTERS
HEALTH-CORONAVIRUS/USA-CONGRESS
RTS3A6KL
June 02, 2020
Judith McMeekin, Associate Commissioner for Regulatory Affairs at the Food and Drug Administration (FDA)...
Washington, United States of America
Senate Finance Committee
Judith McMeekin, Associate Commissioner for Regulatory Affairs at the Food and Drug Administration (FDA) speaks during the Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, U.S., June 2, 2020. Stefani Reynolds/Pool via REUTERS
HEALTH-CORONAVIRUS/USA-CONGRESS
RTS3A6KK
June 02, 2020
Judith McMeekin, Associate Commissioner for Regulatory Affairs at the Food and Drug Administration (FDA)...
Washington, United States of America
Senate Finance Committee
Judith McMeekin, Associate Commissioner for Regulatory Affairs at the Food and Drug Administration (FDA) looks over notes during the Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, U.S., June 2, 2020. Stefani Reynolds/Pool via REUTERS
HEALTH-CORONAVIRUS/USA-CONGRESS
RTS3A6KH
June 02, 2020
Judith McMeekin, Associate Commissioner for Regulatory Affairs at the Food and Drug Administration (FDA)...
Washington, United States of America
Senate Finance Committee
Judith McMeekin, Associate Commissioner for Regulatory Affairs at the Food and Drug Administration (FDA) speaks during the Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, U.S., June 2, 2020. Stefani Reynolds/Pool via REUTERS
HEALTH-CORONAVIRUS/USA-CONGRESS
RTS3A6KG
June 02, 2020
Judith McMeekin, Associate Commissioner for Regulatory Affairs at the Food and Drug Administration (FDA)...
Washington, United States of America
Senate Finance Committee
Judith McMeekin, Associate Commissioner for Regulatory Affairs at the Food and Drug Administration (FDA) listens during the Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, U.S., June 2, 2020. Stefani Reynolds/Pool via REUTERS
HEALTH-CORONAVIRUS/USA-CONGRESS
RTS3A6K6
June 02, 2020
Mark Abdoo, Associate Commissioner for Global Policy and Strategy at the Food and Drug Administration...
Washington, United States of America
Senate Finance Committee
Mark Abdoo, Associate Commissioner for Global Policy and Strategy at the Food and Drug Administration (FDA) speaks during the Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, U.S., June 2, 2020. Stefani Reynolds/Pool via REUTERS
HEALTH-CORONAVIRUS/USA-CONGRESS
RTS3A6K3
June 02, 2020
Mark Abdoo, Associate Commissioner for Global Policy and Strategy at the Food and Drug Administration...
Washington, United States of America
Senate Finance Committee
Mark Abdoo, Associate Commissioner for Global Policy and Strategy at the Food and Drug Administration (FDA) speaks during the Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, U.S., June 2, 2020. Stefani Reynolds/Pool via REUTERS
HEALTH-CORONAVIRUS/USA-CONGRESS
RTS3A6JX
June 02, 2020
Mark Abdoo, Associate Commissioner for Global Policy and Strategy at the Food and Drug Administration...
Washington, United States of America
Senate Finance Committee
Mark Abdoo, Associate Commissioner for Global Policy and Strategy at the Food and Drug Administration (FDA) listens during the Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, U.S., June 2, 2020. Stefani Reynolds/Pool via REUTERS
HEALTH-CORONAVIRUS/USA-CONGRESS
RTS3A6JT
June 02, 2020
Mark Abdoo, Associate Commissioner for Global Policy and Strategy at the Food and Drug Administration...
Washington, United States of America
U.S. Senate Hearing: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process
Mark Abdoo, Associate Commissioner for Global Policy and Strategy at the Food and Drug Administration (FDA) listens during the United States Senate Committee on Finance hearing regarding the inspection process of foreign drug manufacturing on Capitol Hill in Washington D.C., U.S., on Tuesday, June 2, 2020. Stefani Reynolds/Pool via REUTERS
HEALTH-CORONAVIRUS/USA-CONGRESS
RTS3A6JS
June 02, 2020
Mark Abdoo, Associate Commissioner for Global Policy and Strategy at the Food and Drug Administration...
Washington, United States of America
Senate Finance Committee
Mark Abdoo, Associate Commissioner for Global Policy and Strategy at the Food and Drug Administration (FDA) listens during the Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, U.S., June 2, 2020. Stefani Reynolds/Pool via REUTERS
HEALTH-CORONAVIRUS/USA-CONGRESS
RTS3A6JR
June 02, 2020
Mark Abdoo, Associate Commissioner for Global Policy and Strategy at the Food and Drug Administration...
Washington, United States of America
Senate Finance Committee
Mark Abdoo, Associate Commissioner for Global Policy and Strategy at the Food and Drug Administration (FDA) listens during the Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, U.S., June 2, 2020. Stefani Reynolds/Pool via REUTERS
HEALTH-CORONAVIRUS/USA-CONGRESS
RTS3A6HS
June 02, 2020
Associate Commissioner for Regulatory Affairs, Office of Regulatory Affairs Food and Drug Administration,...
Washington, UNITED STATES
Senate Finance Committee
Associate Commissioner for Regulatory Affairs, Office of Regulatory Affairs Food and Drug Administration, Judith A. McMeekin and Associate Commissioner for Global Policy and Strategy at the Food and Drug Administration Mark Abdoo look on during a Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, U.S., June 2, 2020. Andrew Caballero-Reynolds/Pool via REUTERS
HEALTH-CORONAVIRUS/USA-CONGRESS
RTS3A6G7
June 02, 2020
Associate Commissioner for Global Policy and Strategy at the Food and Drug Administration, Mark Abdoo...
Washington, UNITED STATES
Senate Finance Committee
Associate Commissioner for Global Policy and Strategy at the Food and Drug Administration, Mark Abdoo speaks during a Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, U.S., June 2, 2020. Andrew Caballero-Reynolds/Pool via REUTERS
HEALTH-CORONAVIRUS/USA-CONGRESS
RTS3A6G3
June 02, 2020
Associate Commissioner for Global Policy and Strategy at the Food and Drug Administration, Mark Abdoo...
Washington, UNITED STATES
Senate Finance Committee
Associate Commissioner for Global Policy and Strategy at the Food and Drug Administration, Mark Abdoo speaks during a Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, U.S., June 2, 2020. Andrew Caballero-Reynolds/Pool via REUTERS
HEALTH-CORONAVIRUS/USA-CONGRESS
RTS3A6G2
June 02, 2020
Associate Commissioner for Global Policy and Strategy at the Food and Drug Administration, Mark Abdoo...
Washington, UNITED STATES
Senate Finance Committee
Associate Commissioner for Global Policy and Strategy at the Food and Drug Administration, Mark Abdoo speaks during a Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, U.S., June 2, 2020. Andrew Caballero-Reynolds/Pool via REUTERS
HEALTH-CORONAVIRUS/USA-CONGRESS
RTS3A6FJ
June 02, 2020
Associate Commissioner for Global Policy and Strategy at the Food and Drug Administration, Mark Abdoo...
Washington, UNITED STATES
Senate Finance Committee
Associate Commissioner for Global Policy and Strategy at the Food and Drug Administration, Mark Abdoo speaks during a Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, U.S., June 2, 2020. Andrew Caballero-Reynolds/Pool via REUTERS
HEALTH-CORONAVIRUS/USA-CONGRESS
RTS3A6F3
June 02, 2020
Associate Commissioner for Regulatory Affairs, Office of Regulatory Affairs Food and Drug Administration,...
Washington, UNITED STATES
Senate Finance Committee
Associate Commissioner for Regulatory Affairs, Office of Regulatory Affairs Food and Drug Administration, Judith A. McMeekin speaks during a Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, U.S., June 2, 2020. Andrew Caballero-Reynolds/Pool via REUTERS
HEALTH-CORONAVIRUS/USA-CONGRESS
RTS3A6F2
June 02, 2020
Associate Commissioner for Regulatory Affairs, Office of Regulatory Affairs Food and Drug Administration,...
Washington, UNITED STATES
Senate Finance Committee
Associate Commissioner for Regulatory Affairs, Office of Regulatory Affairs Food and Drug Administration, Judith A. McMeekin looks on during a Senate Finance Committee hearing on "COVID-19 and Beyond: Oversight of the FDA's Foreign Drug Manufacturing Inspection Process" at the US Capitol in Washington, U.S., June 2, 2020. Andrew Caballero-Reynolds/Pool via REUTERS
ISRAEL-PALESTINIANS/TRADE
RTS31D1N
February 09, 2020
Lion sculptures are seen in a Palestinian agricultural field in Jordan Valley in the Israeli-occupied...
Jordan Valley, Palestinian Territories
Lion sculptures are seen in a Palestinian agricultural field in Jordan Valley in the Israeli-occupied...
Lion sculptures are seen in a Palestinian agricultural field in Jordan Valley in the Israeli-occupied West Bank February 9, 2020. REUTERS/Mohamad Torokman
CHINA-HEALTH/MYANMAR-FARMER
RTS314Z9
February 07, 2020
Rotten melons are pictured in a farm in Madauk, Bago, Myanmar, February 6, 2020. Picture taken on February...
Bago, Myanmar
Rotten melons are pictured in a farm in Madauk, Bago
Rotten melons are pictured in a farm in Madauk, Bago, Myanmar, February 6, 2020. Picture taken on February 6. REUTERS/Ann Wang
CHINA-HEALTH/MYANMAR-FARMER
RTS314YK
February 07, 2020
A worker packs a melon to send to Yangon for sale in Madauk, Bago, Myanmar, February 6, 2020. Pictures...
Bago, Myanmar
A worker packs a melon to send to Yangon for sale in Madauk, Bago
A worker packs a melon to send to Yangon for sale in Madauk, Bago, Myanmar, February 6, 2020. Pictures taken on February 6. REUTERS/Ann Wang
SIME DARBY PLANT-MALAYSIA/
RTS30V97
February 05, 2020
A palm oil seed is seen at a plantation in Pulau Carey, Malaysia, January 31, 2020. Picture taken January...
PULAU CAREY, Malaysia
A palm oil seed is seen at a plantation in Pulau Carey
A palm oil seed is seen at a plantation in Pulau Carey, Malaysia, January 31, 2020. Picture taken January 31, 2020. REUTERS/Lim Huey Teng
USA-ELECTION/
RTS2ZA81
January 21, 2020
Corn is loaded into a truck to be transported for ethanol production in Kelley, Iowa, U.S., January 21,...
KELLEY, UNITED STATES
Corn is loaded into a truck to be transported for ethanol production in Kelley, Iowa
Corn is loaded into a truck to be transported for ethanol production in Kelley, Iowa, U.S., January 21, 2020. REUTERS/Shannon Stapleton TPX IMAGES OF THE DAY
BRITAIN-AFRICA/INVESTMENT
RTS2Z48K
January 20, 2020
Boxes filled with nectarines are seen at Epping Market near Cape Town, South Africa January 20, 2020....
Cape Town, South Africa
Boxes filled with nectarines are seen at Epping Market near Cape Town
Boxes filled with nectarines are seen at Epping Market near Cape Town, South Africa January 20, 2020. REUTERS/Sumaya Hisham
CLIMATE-CHANGE/GERMANY-COAL
RTS2YMSH
January 16, 2020
A stop sign is pictured in the Hambach Forest, near the town of Buir, Germany, January 16, 2020. REUTERS/Wolfgang...
BUIR, Germany
A stop sign is pictured in the Hambach Forest
A stop sign is pictured in the Hambach Forest, near the town of Buir, Germany, January 16, 2020. REUTERS/Wolfgang Rattay
PHILIPPINES-DAILYLIFE/
RTS2XV00
January 10, 2020
Fish for sale are pictured at a market in Quiapo, Manila, Philippines, January 10, 2020. REUTERS/Willy...
Manila, Philippines
Fish for sale are pictured at a market in Quiapo, Manila
Fish for sale are pictured at a market in Quiapo, Manila, Philippines, January 10, 2020. REUTERS/Willy Kurniawan
USA-TRADE/CHINA-AGRICULTURE
RTS2WYWH
January 03, 2020
Frozen corn is seen on a farm near East Grand Forks, Minnesota, U.S., November 22, 2019. Picture taken...
EAST GRAND FORKS, UNITED STATES
Frozen corn is seen on a farm in East Grand Forks
Frozen corn is seen on a farm near East Grand Forks, Minnesota, U.S., November 22, 2019. Picture taken November 22, 2019. REUTERS/Nicholas Pfosi
USA-TRADE/CHINA-AGRICULTURE
RTS2WYWG
January 03, 2020
Frozen corn is seen on a farm near East Grand Forks, Minnesota, U.S., November 22, 2019. Picture taken...
EAST GRAND FORKS, UNITED STATES
Frozen corn is seen on a farm in East Grand Forks
Frozen corn is seen on a farm near East Grand Forks, Minnesota, U.S., November 22, 2019. Picture taken November 22, 2019. REUTERS/Nicholas Pfosi
USA-TRADE/CHINA-AGRICULTURE
RTS2WYWC
January 03, 2020
Frozen corn is seen on a farm near East Grand Forks, Minnesota, U.S., November 22, 2019. Picture taken...
EAST GRAND FORKS, UNITED STATES
Frozen corn is seen on a farm in East Grand Forks
Frozen corn is seen on a farm near East Grand Forks, Minnesota, U.S., November 22, 2019. Picture taken November 22, 2019. REUTERS/Nicholas Pfosi
USA-TRADE/CHINA-AGRICULTURE
RTS2WYWB
January 03, 2020
Frozen corn is seen on a farm near East Grand Forks, Minnesota, U.S., November 22, 2019. Picture taken...
EAST GRAND FORKS, UNITED STATES
Frozen corn is seen on a farm in East Grand Forks
Frozen corn is seen on a farm near East Grand Forks, Minnesota, U.S., November 22, 2019. Picture taken November 22, 2019. REUTERS/Nicholas Pfosi
USA-TRADE/CHINA-AGRICULTURE
RTS2WYW9
January 03, 2020
Frozen corn is seen on a farm near East Grand Forks, Minnesota, U.S., November 22, 2019. Picture taken...
EAST GRAND FORKS, UNITED STATES
Frozen corn is seen on a farm in East Grand Forks
Frozen corn is seen on a farm near East Grand Forks, Minnesota, U.S., November 22, 2019. Picture taken November 22, 2019. REUTERS/Nicholas Pfosi
USA-TRADE/CHINA-AGRICULTURE
RTS2WYW8
January 03, 2020
Frozen corn is seen on a farm near East Grand Forks, Minnesota, U.S., November 22, 2019. Picture taken...
EAST GRAND FORKS, UNITED STATES
Frozen corn is seen on a farm in East Grand Forks
Frozen corn is seen on a farm near East Grand Forks, Minnesota, U.S., November 22, 2019. Picture taken November 22, 2019. REUTERS/Nicholas Pfosi
Sort by
Display
Items per page
Page
of 75